Archive for January, 2013

The ‘Cooke Look’: SPIE Congratulates Optics Firm on Oscar for…

Cooke Optics has been designing and developing lenses for cinematographers beginning with the very first, and is being recognized with the Academy of Motion Picture Arts and Sciences’ highest…

(PRWeb January 10, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10309609.htm


David Smith Named Vice President of Operations for HealthTell

HealthTell, developer of early screening tests for cancer and other chronic diseases, announced today that it has appointed Dr. David Smith to the position of Vice President of Operations.(PRWeb January 10, 2013)Read the full story at http://www.prw…


Precision Coating to Showcase Next Generation Coating Deposition…

Precision Coating Company, a leader in fluoropolymer coating applications, to demonstrate new state of the art automation of Teflon/PTFE coating deposition technology at MD&M West Trade Show in…(PRWeb January 10, 2013)Read the full story at ht…


AMRESCO Expands Facilities and Upgrades Infrastructure to Keep Pace…

AMRESCO invests in facilities expansion and upgrades to better serve their Custom Manufacturing and Research Products divisions.(PRWeb January 10, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10302195.htm


Chemical Publishing Company Seeking Authors for Definitive Title on…

Potential Authors, Corporations and Universities that wish to publish materials on the subject of hydraulic fracturing are encouraged to submit full or partial manuscripts to Chemical Publishing…(PRWeb January 10, 2013)Read the full story at http:…


Texas Fertility Center Responds to Dateline Story on IVF Lab Mix-Up

TFC & Austin IVF laboratory protocols ensure that mistakes are nearly ‘inconceivable’ in Austin, San Antonio and Central Texas.

(PRWeb January 10, 2013)

Read the full story at http://www.prweb.com/releases/2013/IVF/prweb10302449.htm


Drug Patent Expirations for Dec 29 2012

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations


ADVERTISE
HERE

This
newsletter is a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Simple flat-rate database subscription
plans

Ultimate Plan Premium
Plan
Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe
Plan
comparison
    Site
tour
    Discount
schedule
    Contact





Drug Patent Expirations for December 29 2012

Tradename Applicant Generic Name Patent
Expiration
MAXALT Merck rizatriptan benzoate Dec 29, 2012
MAXALT-MLT Merck rizatriptan benzoate Dec 29, 2012

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.







DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.